top of page
LISTEN TO THE POD
EMAIL SUBSCRIBE
WATCH ON THE PEN
🏠 HOME
📰 GLP-1 NEWS
📺 LIVE SHOW
🌕 ABOUT
OTP BOOK
💉 SHED
More
Use tab to navigate through the menu items.
Log In
NEW GLP3 FROM NOVO NORDISK! BETTER THAN RETATRUTIDE?
Better Blood Sugars, More Weight Loss With Orforglipron VS Rybelsus
EXCLUSIVE: FDA Removes Suicidal Ideation, Depression Language From Obesity GLP-1 Labels After Class-Wide Review
MASSIVE Winter Storm Could Spoil Your GLP-1 Meds
OTP EXLCUSIVE: Mounjaro and Zepbound MULTI-USE Vials Coming Soon!
ZEPBOUND + TALTZ Improves Psoriatic Arthritis Symptoms in Phase 3b Trial!
BREAKING: Zepbound Savings Card 2026 What We Know, Don’t Know, and Why the Silence Is Its Own Story
Zepbound Self Pay Prices Drop Across All Doses Effective Today
Exclusive: FDA Adds Hair Loss to Zepbound’s Side Effects
OTP EXCLUSIVE: What the New FDA Breastfeeding Study Means for Moms on Zepbound and Mounjaro
False and Misleading: What the FDA Says About Zepbound, Mounjaro, Wegovy
The Week Obesity Medicine Shook: Generics, MASH, CV Claims, and Lilly’s Exit
The Podcast Is Live Today! Join Us!
AS SEEN IN
bottom of page